Quarterly report [Sections 13 or 15(d)]

REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)

v3.25.2
REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)
6 Months Ended
Jun. 30, 2025
REVENUES FROM CONTRACTS WITH CUSTOMERS  
Schedule of disaggregation of net revenues

Three-Month Periods Ended June 30,

Six-Month Periods Ended June 30,

($ in thousands)

    

2025

    

2024

    

2025

    

2024

EmrosiTM

$

2,795

$

$

4,865

$

Qbrexza®

6,949

6,836

12,110

11,853

Accutane®

 

3,395

 

5,719

 

7,050

 

11,538

Amzeeq®

879

1,205

1,979

1,960

Zilxi®

256

369

682

642

Other / legacy

735

726

1,462

1,892

Total product revenues

$

15,009

$

14,855

$

28,148

$

27,885